|
GB9919413D0
(en)
*
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
WO2001032621A1
(en)
*
|
1999-10-29 |
2001-05-10 |
Wakunaga Pharmaceutical Co., Ltd. |
Novel indole derivatives and drugs containing the same as the active ingredient
|
|
BR0208956A
(pt)
*
|
2001-04-16 |
2004-07-13 |
Tanabe Seiyaku Co |
Abridor de canais de k ativados por cálcio de grande condutância
|
|
BRPI0211844B8
(pt)
|
2001-08-10 |
2021-05-25 |
Nippon Chemiphar Co |
composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
|
|
KR100933652B1
(ko)
|
2001-10-12 |
2009-12-23 |
닛뽕 케미파 가부시키가이샤 |
페록시좀 증식제 응답성 수용체 δ의 활성화제
|
|
MX2007000481A
(es)
*
|
2004-07-14 |
2007-03-29 |
Ptc Therapeutics Inc |
Metodos para tratar hepatitis c.
|
|
US7598397B2
(en)
*
|
2004-10-12 |
2009-10-06 |
Decode Genetics Ehf |
Sulfonamide peri-substituted bicyclics for occlusive artery disease
|
|
WO2006046683A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Astellas Pharma Inc. |
Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
|
|
GB2431927B
(en)
*
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
CN101460458A
(zh)
*
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
AU2007214434B2
(en)
*
|
2006-02-15 |
2012-06-14 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
NZ572268A
(en)
|
2006-04-18 |
2011-09-30 |
Nippon Chemiphar Co |
Activating agent for peroxisome proliferator activated receptor delta (ppar)
|
|
DE102006021733A1
(de)
*
|
2006-05-09 |
2007-11-22 |
Bayer Healthcare Ag |
3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
|
|
US7579483B2
(en)
*
|
2006-05-16 |
2009-08-25 |
Decode Genetics, Ehf. |
Process for preparing 7-(acryloyl)indoles
|
|
DE102006043443A1
(de)
*
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Neue aza-bicyclische Verbindungen und ihre Verwendung
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
KR20090101307A
(ko)
*
|
2007-01-11 |
2009-09-24 |
알러간, 인코포레이티드 |
스핑고신-1-포스페이트(ｓ1ｐ) 수용체 길항제 생물학적 활성을 갖는 6-치환된 인돌-3-카르복실산 아미드 화합물
|
|
JP5474769B2
(ja)
|
2008-04-15 |
2014-04-16 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体の活性化剤
|
|
US8546431B2
(en)
|
2008-10-01 |
2013-10-01 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
CA2792844C
(en)
|
2010-03-12 |
2014-12-09 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
WO2012087833A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Hepatitis c inhibitors and uses thereof
|
|
KR20150119871A
(ko)
|
2013-02-21 |
2015-10-26 |
아드베리오 파마 게엠베하 |
메틸 ｛4,6-디아미노-2-[1-(2-플루오로벤질)-1H-피라졸로[3,4-b]피리디노-3-일]피리미디노-5-일｝메틸 카르바메이트의 형태
|
|
NZ630810A
(en)
|
2014-04-28 |
2016-03-31 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
NZ630803A
(en)
|
2014-04-28 |
2016-03-31 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
WO2016033445A1
(en)
|
2014-08-29 |
2016-03-03 |
Chdi Foundation, Inc. |
Probes for imaging huntingtin protein
|
|
US9879002B2
(en)
|
2015-04-24 |
2018-01-30 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
JP2018535969A
(ja)
|
2015-11-04 |
2018-12-06 |
オメロス コーポレーション |
Ｐｄｅ１０阻害剤の固体状態形態
|
|
AU2018367909B2
(en)
|
2017-11-17 |
2022-03-10 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of eye disorders
|